Anuh Pharma Ltd vs Corona Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Anuh Pharma Ltd is ₹ 77.77 as of 18 May 15:30 . The P/E Ratio of Anuh Pharma Ltd is 0 as of March 2023 .The P/E Ratio of Corona Remedies Ltd is 0 as of March 2023 . The Market Cap of Anuh Pharma Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Corona Remedies Ltd is ₹ 0 crore as of March 2023 . The revenue of Anuh Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Corona Remedies Ltd for the Mar '26 is ₹ 357.48 crore as compare to the Dec '25 revenue of ₹ 344.68 crore. This represent the growth of 3.71% The ebitda of Anuh Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Corona Remedies Ltd for the Mar '26 is ₹ 66.41 crore as compare to the Dec '25 ebitda of ₹ 66.32 crore. This represent the growth of 0.14% The net profit of Anuh Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Corona Remedies Ltd changed from ₹ 29.95 crore to ₹ 45.33 crore over 8 quarters. This represents a CAGR of 23.03% The Dividend Payout of Anuh Pharma Ltd changed from 26.43 % on March 2021 to 15.88 % on March 2025 . This represents a CAGR of -9.69% over 5 yearsThe Dividend Payout of Corona Remedies Ltd changed from 20 % on March 2023 to 30 % on March 2025 . This represents a CAGR of 14.47% over 3 years .

About Anuh Pharma Ltd

Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs).
The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals.
The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals.
It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra. The Company was incorporated on February 19, 1960.
The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra.

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

FAQs for the comparison of Anuh Pharma Ltd and Corona Remedies Ltd

Which company has a larger market capitalization, Anuh Pharma Ltd or Corona Remedies Ltd?

Market cap of Anuh Pharma Ltd is 779 Cr while Market cap of Corona Remedies Ltd is 11,137 Cr

What are the key factors driving the stock performance of Anuh Pharma Ltd and Corona Remedies Ltd?

The stock performance of Anuh Pharma Ltd and Corona Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anuh Pharma Ltd and Corona Remedies Ltd?

As of May 18, 2026, the Anuh Pharma Ltd stock price is INR ₹77.77. On the other hand, Corona Remedies Ltd stock price is INR ₹1821.1.

How do dividend payouts of Anuh Pharma Ltd and Corona Remedies Ltd compare?

To compare the dividend payouts of Anuh Pharma Ltd and Corona Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.